308PDUpdated overall survival (OS) and quality of life...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

308PDUpdated overall survival (OS) and quality of life (QoL) in premenopausal patients (pts) with advanced breast cancer (ABC) who received ribociclib (RIB) or placebo (PBO) plus goserelin and a nonsteroidal aromatase inhibitor (NSAI) in the MONALEESA-7 (ML-7) trial

Lu, Y-S, Bardia, A, Vázquez, R V, Colleoni, M A, Wheatley-Price, P, Im, Y-H, Babu, G, Tripathy, D, Lanoue, B R, Chandiwana, D, Ridolfi, A, Hughes, G, Zarate, J P, Gounaris, I, Harbeck, N
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz242.003
Date:
October, 2019
File:
PDF, 81 KB
2019
Conversion to is in progress
Conversion to is failed